-
Study: Xgeva reduces chances of bone metastasis among prostate cancer patients
THOUSAND OAKS, Calif. — A cancer drug made by Amgen reduced the chances of prostate cancer spreading to the bones, according to results of a late-stage clinical trial presented at the American Urological Association’s annual meeting in Washington.
The phase-3 “Study ‘147” of Xgeva (denosumab) showed that men taking the drug survived for four months longer without the cancer spreading to their bones, compared with those taking placebo.
-
Dove celebrates launch of body wash collection with Close-Up Challenge
ENGLEWOOD, N.J. — Unilever's Dove celebrated the launch of its new Dove VisibleCare body wash collection with a contest that gave one woman the opportunity to get a taste of what celebrities experience on ABC's "Dancing with the Stars."
Kristi Herman, of Jersey City, N.J., was selected from the nearly 1,500 women who entered the Dove Close-Up Challenge and received a week of professional dance training.